{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:47:35Z","timestamp":1790819255383,"version":"4.1.0"},"reference-count":9,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,11,17]],"date-time":"2003-11-17T00:00:00Z","timestamp":1069027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Posttransplantation lymphoproliferative disease (PTLD) presenting as an Epstein\u2010Barr\u2010virus (EBV)\u2013related nasal plasmacytoma developed in a renal\u2010allograft recipient 13 years after transplantation. Systemic dissemination occurred despite immunosuppression withdrawal, surgery, irradiation, and chemotherapy. A nonmyeloablative hematopoietic\u2010stem\u2010cell\u2010transplantation (HSCT) with peripheral blood HSC from the kidney donor was performed. With the onset of graft\u2010versus\u2010host disease, resolution of the systemic disease was demonstrated clinically and molecularly by serial quantification of plasma EBV\u2010DNA. Isolated relapse occurred in the central nervous system (CNS), a known tumour sanctuary site, ultimately leading to death. Nonmyeloablative HSCT might be considered a cellular therapy for PTLD, but possible CNS relapse must be effectively tackled. Am. J. Hematol. 74:283\u2013286, 2003. \u00a9 2003 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.10417","type":"journal-article","created":{"date-parts":[[2003,11,18]],"date-time":"2003-11-18T21:21:36Z","timestamp":1069190496000},"page":"283-286","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of postrenal transplantation lymphoproliferative disease manifesting as plasmacytoma with nonmyeloablative hematopoietic stem cell transplantation from the same kidney donor"],"prefix":"10.1002","volume":"74","author":[{"given":"W.Y.","family":"Au","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.W.","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.L.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,11,17]]},"reference":[{"issue":"28","key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/oxfordjournals.jncimonographs.a024255","article-title":"Post\u2010transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome\u2010associated malignancies","author":"Swinnen L","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200108150-00028"},{"key":"e_1_2_1_4_2","first-page":"8","article-title":"Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop","volume":"14","author":"Harris NL","year":"1997","journal-title":"Semin Diagn Pathol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200209150-00012"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199809000-00005"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2592"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09672-1"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.5.1295"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1069(199906)17:2<45::AID-HON641>3.0.CO;2-6"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.10417","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.10417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T10:59:14Z","timestamp":1700218754000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.10417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,17]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1002\/ajh.10417"],"URL":"https:\/\/doi.org\/10.1002\/ajh.10417","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,17]]}}}